David P Bonita Insider Trading Transactions
Get free email notifications about insider trading for David P Bonita.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David P Bonita. David P Bonita is Director in AMBIT BIOSCIENCES CORP ($AMBI) and Director in SI-BONE, Inc. ($SIBN) and Director in Acutus Medical, Inc. ($AFIB) and Director in Loxo Oncology, Inc. ($LOXO) and Director in ViewRay, Inc. ($VRAY) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and Director in IMARA Inc. ($IMRA) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Repare Therapeutics Inc. ($RPTX) and Director in Ikena Oncology, Inc. ($IKNA).
Latest Insider Trading Transactions of David P Bonita
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AFIB, AMBI, IKNA, IMRA, LOXO, PRLD, RPTX, SIBN, TCDA, VRAY
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | A | 31.02 | 23,344 | 724,131 | 23,344 | |
May 14 2021 | RPTX | Repare Therapeutic ... | Bonita David P | Director | Option Exercise | A | 32.44 | 21,000 | 681,240 | 21,000 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 68,978 | 0 | 0 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 130,924 | 0 | 0 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 328,907 | 0 | 0 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 920,484 | 0 | 0 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 806,752 | 0 | 0 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 2,257,785 | 0 | 0 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 680,766 | 0 | 0 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 1,905,201 | 0 | 0 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | A | 0.00 | 1,430,103 | 0 | 1,430,103 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | A | 0.00 | 8,938,148 | 0 | 8,938,148 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Buy | C | 0.00 | 130,924 | 0 | 130,924 | 0 to 130.9 K |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Buy | C | 0.00 | 5,083,470 | 0 | 5,083,470 | 0 to 5.1 M |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Buy | P | 16.00 | 48,400 | 774,400 | 117,378 | 69 K to 117.4 K (+70.17 %) |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Buy | P | 16.00 | 375,000 | 6,000,000 | 2,191,425 | 1.8 M to 2.2 M (+20.64 %) |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Buy | C | 0.00 | 68,978 | 0 | 68,978 | 0 to 69 K |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Buy | C | 0.00 | 1,816,425 | 0 | 1,816,425 | 0 to 1.8 M |
Jan 12 2021 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | P | 0.00 | 41,700 | 0 | 5,596,886 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 5,555,186 | 0 | 5,555,186 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 413,234 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 619,850 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 2,945,458 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 4,418,186 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 2,196,494 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 3,294,743 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | P | 0.00 | 1,033,084 | 0 | 1,033,084 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | P | 0.00 | 3,681,822 | 0 | 7,363,644 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | A | 12.85 | 46,688 | 599,941 | 46,688 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Buy | C | 0.00 | 8,332,779 | 0 | 9,250,191 | 917.4 K to 9.3 M (+908.29 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Buy | P | 19.00 | 710,500 | 13,499,500 | 917,412 | 206.9 K to 917.4 K (+343.38 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Buy | P | 19.00 | 526,300 | 9,999,700 | 526,300 | 0 to 526.3 K |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 5,555,186 | 0 | 5,555,186 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 413,234 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 619,850 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 2,945,458 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 4,418,186 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 2,196,494 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | C | 0.00 | 3,294,743 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | P | 0.00 | 1,033,084 | 0 | 1,033,084 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | P | 0.00 | 3,681,822 | 0 | 7,363,644 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Option Exercise | A | 12.85 | 46,688 | 599,941 | 46,688 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Buy | C | 0.00 | 8,332,779 | 0 | 9,250,191 | 917.4 K to 9.3 M (+908.29 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Buy | P | 19.00 | 710,500 | 13,499,500 | 917,412 | 206.9 K to 917.4 K (+343.38 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | Bonita David P | Director | Buy | P | 19.00 | 526,300 | 9,999,700 | 526,300 | 0 to 526.3 K |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 378,733 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 1,202,117 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 389,116 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 899,985 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 647,582 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 673,123 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 872,302 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Bonita David P | Director | Buy | C | 0.00 | 1,278,718 | 0 | 1,320,218 | 41.5 K to 1.3 M (+3,081.25 %) |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Bonita David P | Director | Buy | C | 0.00 | 3,784,240 | 0 | 4,157,740 | 373.5 K to 4.2 M (+1,013.18 %) |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Bonita David P | Director | Buy | P | 18.00 | 41,500 | 747,000 | 41,500 | 0 to 41.5 K |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Bonita David P | Director | Buy | P | 18.00 | 373,500 | 6,723,000 | 373,500 | 0 to 373.5 K |
Aug 07 2020 | AFIB | Acutus Medical, In ... | Bonita David P | Director | Option Exercise | A | 18.00 | 12,454 | 224,172 | 12,454 | |
Aug 07 2020 | AFIB | Acutus Medical, In ... | Bonita David P | Director | Grant | A | 0.00 | 2,222 | 0 | 2,222 | 0 to 2.2 K |
Jun 25 2020 | RPTX | Repare Therapeutic ... | Bonita David P | Director | Option Exercise | C | 0.00 | 2,601,325 | 0 | 0 | |
Jun 25 2020 | RPTX | Repare Therapeutic ... | Bonita David P | Director | Buy | P | 20.00 | 99,200 | 1,984,000 | 99,200 | 0 to 99.2 K |
Jun 25 2020 | RPTX | Repare Therapeutic ... | Bonita David P | Director | Buy | P | 20.00 | 675,000 | 13,500,000 | 3,276,325 | 2.6 M to 3.3 M (+25.95 %) |
Jun 25 2020 | RPTX | Repare Therapeutic ... | Bonita David P | Director | Buy | C | 0.00 | 2,601,325 | 0 | 2,601,325 | 0 to 2.6 M |
Jun 15 2020 | TCDA | Tricida, Inc. | Bonita David P | Director | Option Exercise | A | 25.40 | 22,967 | 583,362 | 22,967 | |
Jun 15 2020 | TCDA | Tricida, Inc. | Bonita David P | Director | Grant | A | 0.00 | 5,670 | 0 | 11,181 | 5.5 K to 11.2 K (+102.89 %) |
Mar 16 2020 | IMRA | IMARA Inc. | Bonita David P | Director | Option Exercise | A | 16.00 | 15,457 | 247,312 | 15,457 | |
Mar 16 2020 | IMRA | IMARA Inc. | Bonita David P | Director | Option Exercise | C | 0.00 | 10,046,294 | 0 | 0 | |
Mar 16 2020 | IMRA | IMARA Inc. | Bonita David P | Director | Buy | C | 0.00 | 1,594,902 | 0 | 2,532,402 | 937.5 K to 2.5 M (+170.12 %) |
Mar 16 2020 | IMRA | IMARA Inc. | Bonita David P | Director | Buy | P | 16.00 | 937,500 | 15,000,000 | 937,500 | 0 to 937.5 K |
Dec 12 2019 | TCDA | Tricida, Inc. | Bonita David P | Director | Sell | S | 40.00 | 1,500,000 | 60,000,000 | 9,614,280 | 11.1 M to 9.6 M (-13.50 %) |
Jun 04 2019 | TCDA | Tricida, Inc. | Bonita David P | Director | Option Exercise | A | 36.74 | 7,068 | 259,678 | 7,068 | |
Jun 04 2019 | TCDA | Tricida, Inc. | Bonita David P | Director | Grant | A | 0.00 | 1,879 | 0 | 5,511 | 3.6 K to 5.5 K (+51.73 %) |
Apr 05 2019 | TCDA | Tricida, Inc. | Bonita David P | Director | Buy | P | 36.00 | 225,000 | 8,100,000 | 11,114,280 | 10.9 M to 11.1 M (+2.07 %) |
Oct 19 2018 | SIBN | SI-BONE, Inc. | Bonita David P | Director | Option Exercise | C | 0.00 | 179,404 | 0 | 0 | |
Oct 19 2018 | SIBN | SI-BONE, Inc. | Bonita David P | Director | Option Exercise | C | 0.00 | 572,326 | 0 | 0 | |
Oct 19 2018 | SIBN | SI-BONE, Inc. | Bonita David P | Director | Buy | P | 15.00 | 200,000 | 3,000,000 | 985,368 | 785.4 K to 985.4 K (+25.47 %) |
Oct 19 2018 | SIBN | SI-BONE, Inc. | Bonita David P | Director | Buy | C | 0.00 | 179,404 | 0 | 785,368 | 606 K to 785.4 K (+29.61 %) |
Oct 19 2018 | SIBN | SI-BONE, Inc. | Bonita David P | Director | Buy | C | 0.00 | 605,964 | 0 | 605,964 | 0 to 606 K |
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Option Exercise | A | 19.00 | 13,147 | 249,793 | 13,147 | ||
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Option Exercise | A | 19.00 | 13,147 | 249,793 | 13,147 | ||
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Option Exercise | C | 0.00 | 4,255,319 | 0 | 0 | ||
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Option Exercise | C | 0.00 | 4,255,319 | 0 | 0 | ||
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Option Exercise | C | 0.00 | 14,292,958 | 0 | 0 | ||
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Option Exercise | C | 0.00 | 14,292,958 | 0 | 0 | ||
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Option Exercise | C | 0.00 | 17,117,085 | 0 | 0 | ||
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Option Exercise | C | 0.00 | 17,117,085 | 0 | 0 | ||
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Option Exercise | C | 0.00 | 6,207,674 | 0 | 0 | ||
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Option Exercise | C | 0.00 | 6,207,674 | 0 | 0 | ||
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Grant | A | 0.00 | 3,632 | 0 | 3,632 | 0 to 3.6 K | |
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Grant | A | 0.00 | 3,632 | 0 | 3,632 | 0 to 3.6 K | |
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Buy | P | 19.00 | 368,421 | 6,999,999 | 10,889,280 | 10.5 M to 10.9 M (+3.50 %) | |
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Buy | P | 19.00 | 368,421 | 6,999,999 | 10,889,280 | 10.5 M to 10.9 M (+3.50 %) | |
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Buy | C | 0.00 | 1,069,175 | 0 | 10,520,859 | 9.5 M to 10.5 M (+11.31 %) | |
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Buy | C | 0.00 | 1,069,175 | 0 | 10,520,859 | 9.5 M to 10.5 M (+11.31 %) | |
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Buy | C | 0.00 | 3,591,194 | 0 | 9,451,684 | 5.9 M to 9.5 M (+61.28 %) | |
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Buy | C | 0.00 | 3,591,194 | 0 | 9,451,684 | 5.9 M to 9.5 M (+61.28 %) | |
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Buy | C | 0.00 | 4,300,774 | 0 | 5,860,490 | 1.6 M to 5.9 M (+275.74 %) | |
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Buy | C | 0.00 | 4,300,774 | 0 | 5,860,490 | 1.6 M to 5.9 M (+275.74 %) | |
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Buy | C | 0.00 | 1,559,716 | 0 | 1,559,716 | 0 to 1.6 M | |
Jul 02 2018 | TCDA | Tricida, Inc. | Bonita David P | Buy | C | 0.00 | 1,559,716 | 0 | 1,559,716 | 0 to 1.6 M | |
Apr 25 2018 | VRAY | ViewRay, Inc. | Bonita David P | Director | Option Exercise | A | 8.02 | 45,633 | 365,977 | 45,633 | |
Apr 25 2018 | VRAY | ViewRay, Inc. | Bonita David P | Director | Grant | A | 0.00 | 6,857 | 0 | 26,388 | 19.5 K to 26.4 K (+35.11 %) |
Dec 12 2017 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Sell | S | 82.50 | 250,000 | 20,625,000 | 941,000 | 1.2 M to 941 K (-20.99 %) |
Nov 27 2017 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Sell | S | 75.00 | 267,000 | 20,025,000 | 1,191,000 | 1.5 M to 1.2 M (-18.31 %) |
Nov 20 2017 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Sell | S | 76.23 | 8,377 | 638,579 | 1,458,000 | 1.5 M to 1.5 M (-0.57 %) |
Nov 20 2017 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Sell | S | 75.37 | 71,598 | 5,396,341 | 1,466,377 | 1.5 M to 1.5 M (-4.66 %) |
Nov 20 2017 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Sell | S | 74.49 | 100,045 | 7,452,352 | 1,537,975 | 1.6 M to 1.5 M (-6.11 %) |
Nov 20 2017 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Sell | S | 73.48 | 43,300 | 3,181,684 | 1,638,020 | 1.7 M to 1.6 M (-2.58 %) |
Nov 20 2017 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Sell | S | 72.46 | 46,680 | 3,382,433 | 1,681,320 | 1.7 M to 1.7 M (-2.70 %) |
Jun 23 2017 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Option Exercise | A | 78.58 | 11,000 | 864,380 | 11,000 | |
Jan 20 2017 | VRAY | ViewRay, Inc. | Bonita David P | Director | Option Exercise | P | 3.17 | 623 | 1,975 | 3,843 | |
Jan 20 2017 | VRAY | ViewRay, Inc. | Bonita David P | Director | Option Exercise | P | 3.17 | 65,491 | 207,606 | 403,692 | |
Jan 20 2017 | VRAY | ViewRay, Inc. | Bonita David P | Director | Buy | P | 3.00 | 3,118 | 9,354 | 89,225 | 86.1 K to 89.2 K (+3.62 %) |
Jan 20 2017 | VRAY | ViewRay, Inc. | Bonita David P | Director | Buy | P | 3.00 | 327,459 | 982,377 | 9,369,342 | 9 M to 9.4 M (+3.62 %) |
Sep 15 2016 | VRAY | ViewRay, Inc. | Bonita David P | Director | Grant | A | 0.00 | 19,531 | 0 | 19,531 | 0 to 19.5 K |
Aug 24 2016 | VRAY | ViewRay, Inc. | Bonita David P | Director | Option Exercise | P | 2.95 | 3,220 | 9,499 | 3,220 | |
Aug 24 2016 | VRAY | ViewRay, Inc. | Bonita David P | Director | Option Exercise | P | 2.95 | 338,201 | 997,693 | 338,201 | |
Aug 24 2016 | VRAY | ViewRay, Inc. | Bonita David P | Director | Buy | P | 2.95 | 10,736 | 31,671 | 86,107 | 75.4 K to 86.1 K (+14.24 %) |
Aug 24 2016 | VRAY | ViewRay, Inc. | Bonita David P | Director | Buy | P | 2.95 | 1,127,338 | 3,325,647 | 9,041,883 | 7.9 M to 9 M (+14.24 %) |
Aug 12 2016 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Sell | S | 26.96 | 447,857 | 12,074,225 | 1,728,000 | 2.2 M to 1.7 M (-20.58 %) |
Jun 13 2016 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Option Exercise | A | 24.18 | 7,812 | 188,894 | 7,812 | |
Jul 30 2015 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Option Exercise | A | 20.91 | 7,812 | 163,349 | 7,812 | |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Option Exercise | A | 6.66 | 7,085 | 47,186 | 7,085 | |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Option Exercise | C | 0.00 | 18,795 | 0 | 0 | |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Option Exercise | C | 0.00 | 1,973,439 | 0 | 0 | |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Option Exercise | C | 0.00 | 50,256 | 0 | 0 | |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Option Exercise | C | 0.00 | 5,276,702 | 0 | 0 | |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Option Exercise | C | 0.00 | 83,959 | 0 | 0 | |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Option Exercise | C | 0.00 | 8,815,565 | 0 | 0 | |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Buy | P | 6.90 | 80 | 552 | 13,747 | 13.7 K to 13.7 K (+0.59 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Buy | P | 6.90 | 8,020 | 55,314 | 1,443,222 | 1.4 M to 1.4 M (+0.56 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Buy | P | 8.00 | 590 | 4,720 | 13,667 | 13.1 K to 13.7 K (+4.51 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Buy | P | 8.00 | 61,910 | 495,280 | 1,435,202 | 1.4 M to 1.4 M (+4.51 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Buy | P | 8.00 | 5,653 | 45,224 | 13,077 | 7.4 K to 13.1 K (+76.14 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Buy | P | 8.00 | 593,618 | 4,748,944 | 1,373,292 | 779.7 K to 1.4 M (+76.14 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Buy | C | 0.00 | 1,730 | 0 | 7,424 | 5.7 K to 7.4 K (+30.38 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Buy | C | 0.00 | 181,689 | 0 | 779,674 | 598 K to 779.7 K (+30.38 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Buy | C | 0.00 | 2,094 | 0 | 5,694 | 3.6 K to 5.7 K (+58.17 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Buy | C | 0.00 | 219,863 | 0 | 597,985 | 378.1 K to 598 K (+58.15 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Buy | C | 0.00 | 3,498 | 0 | 3,600 | 102 to 3.6 K (+3,429.41 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Buy | C | 0.00 | 367,315 | 0 | 378,122 | 10.8 K to 378.1 K (+3,398.86 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Buy | P | 6.78 | 100 | 678 | 102 | 2 to 102 (+5,000.00 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | Bonita David P | Director | Buy | P | 6.78 | 10,500 | 71,162 | 10,807 | 307 to 10.8 K (+3,420.20 %) |
Page: 1